Mérédis Favreau
Show
Sort by
-
Checkpoint inhibition in the treatment of multiple myeloma: A way to boost innate-like T cell anti-tumor function?
-
- journalArticle
- A1
- open access
Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition
-
Leptin receptor antagonism of iNKT cell function : a novel strategy to combat multiple myeloma
-
Immune therapy in multiple myeloma : can iNKT cells be targeted?
(2017) -
- journalArticle
- A1
- open access
Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells
-
- journalArticle
- A1
- open access
Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?
-
- journalArticle
- A1
- open access
Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model